|
National Board of Examinations Journal of Medical Sciences (NBEJMS) |
|
|
National Board of Examinations Journal of Medical Sciences (NBEJMS) |
The editorial board of the NBEJMS is seeking papers, which will be refereed. We encourage the authors to submit a Word format (Figures in tiff/jpg format) electronic version of the manuscript in a free format to the Editors-in-Chief of the NBEMS, (E-mail: acad[at]natboard[dot]edu[dot]in). Submitted manuscripts must be written in English and contain the name and affiliation of each author followed by a leading abstract and keywords. The authors must include a "cover letter" presenting their manuscript and mentioning: "We confirm that this manuscript has been read and approved by all named authors. In addition, we declare that the manuscript is original and it is not being published or submitted for publication elsewhere".
We request the authors to prepare the graphical abstract for the article categories: Original Articles, Reviews etc. You can refer the published articles from the website (https://natboard.edu.in/ejournal/index) for the above categories for further information.
JOURNAL POLICIES
Authorship
An ‘author’ is someone who has made substantive intellectual contributions
to a study. In accordance with ICMJE guidelines (www.icmje.org), authorship
credit requires all the following conditions to be met.
All authors should have participated sufficiently in the work to take public responsibility for the content. All authors must sign an undertaking accepting responsibility for the submitted manuscript. Authors are required to state their exact contribution to the study; the Journal may print this information. The order of authorship should be decided by all the authors. The journal strongly discourages alterations in the sequence or deletion/addition of authors at any time after submission of the manuscript.
Acknowledgements
All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or statistical or writing assistance. Financial and material support should also be acknowledged.
Conflict of interest
A conflict of interest exists when a financial or personal relationship of the author may inappropriately influence his or her actions. Conflicts may be personal, commercial, political, academic, or financial. Some examples of financial conflicts of interest include employment, research funding (received or pending), stock or share ownership, payment for lectures or travel, consultancies and non-monetary support. Conflicts, or their absence, must be stated in writing by all authors at the time of submission of the article. The Journal may use information disclosed in conflict of interest and financial interest statements as a basis for editorial decisions. Sources of full or partial funding or other support for the research must be declared. For more information please see www.icmje.org .
Protection of human subjects and animals in research
All studies conducted on human subjects or animals should be approved by the ethics committee or the institutional review board of the institution where the study was performed. When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). When reporting experiments on animals, authors should indicate whether the institutional and national guidelines for the care and use of laboratory animals were followed (see ICMR guidelines: icmr.nic.in/ethics_SOP.pdf and icmr.nic.in/animal_ethics.htm).
Patient confidentiality
Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients’ names, initials or hospital numbers, should not be revealed in written descriptions and photographs. If it is not possible to ensure anonymity, written, informed consent should be obtained from the patient and submitted to the Journal. Identifying details should be omitted if these are not essential but patient data should not be altered to attain anonymity.
Copyright
Authors must agree in writing to transfer to the Journal the copyright for all material submitted, in case of its publication by the Journal.
Plagiarism
Plagiarism is the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. This applies to all forms of documents, published (print or electronic) or unpublished. Authors should make sure that their manuscripts are free from plagiarized material. Providing a reference to the material quoted verbatim from previously published material does not absolve the user of plagiarism. Detection of plagiarism would lead to rejection of the manuscript and debar the publication of any material from the concerned authors for at least three years. The Journal may also send this information to the head of the institution where the authors work with a request for an inquiry in the matter. The Journal may also publish such correspondence in its pages to inform its readers of scientific misconduct.
Dual submission and duplicate publication
The Journal strongly disapproves of ‘Dual submission’, i.e. the submission of the same article simultaneously to different journals for consideration for publication. The authors must give an undertaking (see ‘Author’s declaration’ below) stating that the manuscript has not been submitted to another journal for consideration for publication nor has a substantial part of it been published previously. They should disclose details of any similar or closely-related paper(s) previously published, in press or those currently under review at another Journal. Previous publication of an abstract in the proceedings of meetings (print or electronic) does not preclude subsequent submission for publication, but this information must be provided at the time of submission. In case the manuscript has already been published elsewhere in any form, details of such publication (including a copy of the submitted/published manuscript) and the reason for submission in the present form must be stated at the time of submission in the covering letter. If dual submission or duplicate publication is found to have occurred, the manuscript will be rejected and the authors barred from future submissions. The Journal may also send this information to the head of the institution where the authors work with a request for an inquiry in the matter. The Journal may also publish such correspondence in its pages to inform its readers of scientific misconduct and such papers may be retracted.
Peer Review
All articles submitted to the Journal are peer-reviewed. The process may differ depending upon the category to which the manuscript belongs. Most of the articles are assessed by two reviewers. Peer reviewers are experts in their chosen field who provide the Journal a written assessment of the strengths and weaknesses of manuscripts, with the aim of identifying the most appropriate and best material for the Journal. Authors may suggest the names and addresses of three experts each from India and abroad who, in the authors’ opinion, are best qualified to review the paper. Suggested reviewers should not be recent collaborators or co-authors (within the past 3 years), nor should they have provided substantial advice or critique of the submitted manuscript. Authors may also provide the names of reviewers they wish to be excluded, giving reasons for such a request. The Journal reserves the right to decide on the choice of reviewers. All reviewers are expected to inform the Journal about any conflict of interest while reviewing articles. Also, the journal uses the reviewers from their own database (internal). The final decision of Accept/Reject/Revise would be taken by the Editor-in-Chief.
Ethical Responsibilities of Authors
This journal is committed to upholding the integrity of the scientific record. As a member of the Committee on Publication Ethics (COPE) the journal will follow the COPE guidelines on how to deal with potential acts of misconduct.
Authors should refrain from misrepresenting research results which could damage the trust in the journal, the professionalism of scientific authorship, and ultimately the entire scientific endeavour. Maintaining integrity of the research and its presentation is helped by following the rules of good scientific practice, which include*:
Important note: the journal may use software to screen for plagiarism.
*All of the above are guidelines and authors need to make sure to respect third parties rights such as copyright and/or moral rights.
Upon request authors should be prepared to send relevant documentation or data in order to verify the validity of the results presented. This could be in the form of raw data, samples, records, etc. Sensitive information in the form of confidential or proprietary data is excluded.
If there is suspicion of misbehavior or alleged fraud the Journal and/or Publisher will carry out an investigation following COPE guidelines. If, after investigation, there are valid concerns, the author(s) concerned will be contacted under their given e-mail address and given an opportunity to address the issue. Depending on the situation, this may result in the Journal’s and/or Publisher’s implementation of the following measures, including, but not limited to:
- an erratum/correction may be placed with the article
- an expression of concern may be placed with the article
- or in severe cases retraction of the article may occur.
The reason will be given in the published erratum/correction, expression of concern or retraction note. Please note that retraction means that the article is maintained on the platform, watermarked “retracted” and the explanation for the retraction is provided in a note linked to the watermarked article.
Fundamental errors
Authors have an obligation to correct mistakes once they discover a significant error or inaccuracy in their published article. The author(s) is/are requested to contact the journal and explain in what sense the error is impacting the article. A decision on how to correct the literature will depend on the nature of the error. This may be a correction or retraction. The retraction note should provide transparency which parts of the article are impacted by the error.
Suggesting / excluding reviewers
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts. When suggesting reviewers, authors should make sure they are totally independent and not connected to the work in any way. It is strongly recommended to suggest a mix of reviewers from different countries and different institutions. When suggesting reviewers, the Corresponding Author must provide an institutional email address for each suggested reviewer, or, if this is not possible to include other means of verifying the identity such as a link to a personal homepage, a link to the publication record or a researcher or author ID in the submission letter. Please note that the Journal may not use the suggestions, but suggestions are appreciated and may help facilitate the peer review process.
Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals.
Authors should include the following statements (if applicable) in a separate section entitled “Compliance with Ethical Standards” when submitting a paper:
The corresponding author should be prepared to collect documentation of compliance with ethical standards and send if requested during peer review or after publication.
The Editors reserve the right to reject manuscripts that do not comply with the above-mentioned guidelines. The author will be held responsible for false statements or failure to fulfill the above-mentioned guidelines.
Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclosure of interests provides a complete and transparent process and helps readers form their own judgments of potential bias. This is not meant to imply that a financial relationship with an organization that sponsored the research or compensation received for consultancy work is inappropriate.
Editorial Board Members and Editors are required to declare any competing interests and may be excluded from the peer review process if a competing interest exists. In addition, they should exclude themselves from handling manuscripts in cases where there is a competing interest. This may include – but is not limited to – having previously published with one or more of the authors, and sharing the same institution as one or more of the authors. Where an Editor or Editorial Board Member is on the author list we recommend they declare this in the competing interests section on the submitted manuscript. If they are an author or have any other competing interest regarding a specific manuscript, another Editor or member of the Editorial Board will be assigned to assume responsibility for overseeing peer review. These submissions are subject to the exact same review process as any other manuscript. Editorial Board Members are welcome to submit papers to the journal. These submissions are not given any priority over other manuscripts, and Editorial Board Member status has no bearing on editorial consideration.
Interests that should be considered and disclosed but are not limited to the following:
Funding: Research grants from funding agencies (please give the research funder and the grant number) and/or research support (including salaries, equipment, supplies, reimbursement for attending symposia, and other expenses) by organizations that may gain or lose financially through publication of this manuscript.
Employment: Recent (while engaged in the research project), present or anticipated employment by any organization that may gain or lose financially through publication of this manuscript. This includes multiple affiliations (if applicable).
Financial interests: Stocks or shares in companies (including holdings of spouse and/or children) that may gain or lose financially through publication of this manuscript; consultation fees or other forms of remuneration from organizations that may gain or lose financially; patents or patent applications whose value may be affected by publication of this manuscript.
It is difficult to specify a threshold at which a financial interest becomes significant, any such figure is necessarily arbitrary, so one possible practical guideline is the following: "Any undeclared financial interest that could embarrass the author were it to become publicly known after the work was published."
Non-financial interests: In addition, authors are requested to disclose interests that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others). Examples include, but are not limited to: position on editorial board, advisory board or board of directors or other type of management relationships; writing and/or consulting for educational purposes; expert witness; mentoring relations; and so forth.
Primary research articles require a disclosure statement. Review articles present an expert synthesis of evidence and may be treated as an authoritative work on a subject. Review articles therefore require a disclosure statement. Other article types such as editorials, book reviews, comments (amongst others) may, dependent on their content, require a disclosure statement. If you are unclear whether your article type requires a disclosure statement, please contact the Editor-in-Chief/Editorial Manager.
Please note that, in addition to the above requirements, funding information (given that funding is a potential competing interest (as mentioned above)) needs to be disclosed upon submission of the manuscript. Under ‘summary of requirements’ (see below) funding information should be included in the ‘Declarations’ section.
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Funding’ and/or ‘Competing interests’. Other declarations include Ethics approval, Consent, Data, Material and/or Code availability and Authors’ contribution statements.
Please see the various examples of wording below and revise/customize the sample statements according to your own needs.
When all authors have the same (or no) conflicts and/or funding it is sufficient to use one blanket statement.
Examples of statements to be used when funding has been received:
Examples of statements to be used when there is no funding:
Examples of statements to be used when there are interests to declare:
Non-financial interests: Author C is an unpaid member of committee Z.
Non-financial interests: Author A is on the board of directors of Y and receives no compensation as member of the board of directors.
Non-financial interests: none.
Non-financial interests: Author D has served on advisory boards for Company M, Company N and Company O.
Examples of statements to be used when authors have nothing to declare:
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
Research involving human participants, their data or biological material
Ethics approval
When reporting a study that involved human participants, their data or biological material, authors should include a statement that confirms that the study was approved (or granted exemption) by the appropriate institutional and/or national research ethics committee (including the name of the ethics committee) and certify that the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. If doubt exists whether the research was conducted in accordance with the 1964 Helsinki Declaration or comparable standards, the authors must explain the reasons for their approach, and demonstrate that an independent ethics committee or institutional review board explicitly approved the doubtful aspects of the study. If a study was granted exemption from requiring ethics approval, this should also be detailed in the manuscript (including the reasons for the exemption).
Retrospective ethics approval
If a study has not been granted ethics committee approval prior to commencing, retrospective ethics approval usually cannot be obtained and it may not be possible to consider the manuscript for peer review. The decision on whether to proceed to peer review in such cases is at the Editor's discretion.
Ethics approval for retrospective studies
Although retrospective studies are conducted on already available data or biological material (for which formal consent may not be needed or is difficult to obtain) ethics approval may be required dependent on the law and the national ethical guidelines of a country. Authors should check with their institution to make sure they are complying with the specific requirements of their country.
Ethics approval for case studies
Case reports require ethics approval. Most institutions will have specific policies on this subject. Authors should check with their institution to make sure they are complying with the specific requirements of their institution and seek ethics approval where needed. Authors should be aware to secure informed consent from the individual (or parent or guardian if the participant is a minor or incapable) See also section on Informed Consent .
Cell lines
If human cells are used, authors must declare in the manuscript: what cell lines were used by describing the source of the cell line, including when and from where it was obtained, whether the cell line has recently been authenticated and by what method. If cells were bought from a life science company the following need to be given in the manuscript: name of company (that provided the cells), cell type, number of cell line, and batch of cells.
It is recommended that authors check the NCBI database for misidentification and contamination of human cell lines. This step will alert authors to possible problems with the cell line and may save considerable time and effort.
Further information is available from the International Cell Line Authentication Committee (ICLAC).
Authors should include a statement that confirms that an institutional or independent ethics committee (including the name of the ethics committee) approved the study and that informed consent was obtained from the donor or next of kin.
Research Resource Identifiers (RRID)
Research Resource Identifiers (RRID) are persistent unique identifiers (effectively similar to a DOI) for research resources. This journal encourages authors to adopt RRIDs when reporting key biological resources (antibodies, cell lines, model organisms and tools) in their manuscripts.
Examples:
Organism: Filip1tm1a(KOMP)Wtsi RRID:MMRRC_055641-UCD
Cell Line: RST307 cell line RRID:CVCL_C321
Antibody: Luciferase antibody DSHB Cat# LUC-3, RRID:AB_2722109
Plasmid: mRuby3 plasmid RRID:Addgene_104005
Software: ImageJ Version 1.2.4 RRID:SCR_003070
RRIDs are provided by the Resource Identification Portal . Many commonly used research resources already have designated RRIDs. The portal also provides authors links so that they can quickly register a new resource and obtain an RRID.
Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to assess, improve, maintain, promote or modify health, functioning or health conditions” and a health-related outcome is generally defined as a change in the health of a person or population as a result of an intervention.
To ensure the integrity of the reporting of patient-centered trials, authors must register prospective clinical trials (phase II to IV trials) in suitable publicly available repositories. For example www.clinicaltrials.gov or any of the primary registries that participate in the WHO International Clinical Trials Registry Platform .
The trial registration number (TRN) and date of registration should be included as the last line of the manuscript abstract.
For clinical trials that have not been registered prospectively, authors are encouraged to register retrospectively to ensure the complete publication of all results. The trial registration number (TRN), date of registration and the words 'retrospectively registered’ should be included as the last line of the manuscript abstract.
Standards of reporting
NBEJMS advocates complete and transparent reporting of biomedical and biological research and research with biological applications. Authors are recommended to adhere to the minimum reporting guidelines hosted by the EQUATOR Network when preparing their manuscript.
Exact requirements may vary depending on the journal; please refer to the journal’s Instructions for Authors.
Checklists are available for a number of study designs, including:
Randomised trials (CONSORT) and Study protocols (SPIRIT)
Observational studies (STROBE)
Systematic reviews and meta-analyses (PRISMA) and protocols (Prisma-P)
Diagnostic/prognostic studies (STARD) and (TRIPOD)
Case reports (CARE)
Clinical practice guidelines (AGREE) and (RIGHT)
Qualitative research (SRQR) and (COREQ)
Animal pre-clinical studies (ARRIVE)
Quality improvement studies (SQUIRE)
Economic evaluations (CHEERS)
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Ethics approval’.
Examples of statements to be used when ethics approval has been obtained:
• All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Medical University of A (No. ...).
• This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University B (Date.../No. ...).
• Approval was obtained from the ethics committee of University C. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
• The questionnaire and methodology for this study was approved by the Human Research Ethics committee of the University of D (Ethics approval number: ...).
Examples of statements to be used for a retrospective study:
• Ethical approval was waived by the local Ethics Committee of University A in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
• This research study was conducted retrospectively from data obtained for clinical purposes. We consulted extensively with the IRB of XYZ who determined that our study did not need ethical approval. An IRB official waiver of ethical approval was granted from the IRB of XYZ.
• This retrospective chart review study involving human participants was in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The Human Investigation Committee (IRB) of University B approved this study.
Examples of statements to be used when no ethical approval is required/exemption granted:
• This is an observational study. The XYZ Research Ethics Committee has confirmed that no ethical approval is required.
• The data reproduced from Article X utilized human tissue that was procured via our Biobank AB, which provides de-identified samples. This study was reviewed and deemed exempt by our XYZ Institutional Review Board. The BioBank protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
Informed consent
All individuals have individual rights that are not to be infringed. Individual participants in studies have, for example, the right to decide what happens to the (identifiable) personal data gathered, to what they have said during a study or an interview, as well as to any photograph that was taken. This is especially true concerning images of vulnerable people (e.g. minors, patients, refugees, etc) or the use of images in sensitive contexts. In many instances authors will need to secure written consent before including images.
Identifying details (names, dates of birth, identity numbers, biometrical characteristics (such as facial features, fingerprint, writing style, voice pattern, DNA or other distinguishing characteristic) and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scholarly purposes and the participant (or parent/guardian if the participant is a minor or incapable or legal representative) gave written informed consent for publication. Complete anonymity is difficult to achieve in some cases. Detailed descriptions of individual participants, whether of their whole bodies or of body sections, may lead to disclosure of their identity. Under certain circumstances consent is not required as long as information is anonymized and the submission does not include images that may identify the person.
Informed consent for publication should be obtained if there is any doubt. For example, masking the eye region in photographs of participants is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors should provide assurance that alterations do not distort meaning.
Exceptions where it is not necessary to obtain consent:
• Images such as x rays, laparoscopic images, ultrasound images, brain scans, pathology slides unless there is a concern about identifying information in which case, authors should ensure that consent is obtained.
• Reuse of images: If images are being reused from prior publications, the Publisher will assume that the prior publication obtained the relevant information regarding consent. Authors should provide the appropriate attribution for republished images.
Consent and already available data and/or biologic material
Regardless of whether material is collected from living or dead patients, they (family or guardian if the deceased has not made a pre-mortem decision) must have given prior written consent. The aspect of confidentiality as well as any wishes from the deceased should be respected.
Data protection, confidentiality and privacy
When biological material is donated for or data is generated as part of a research project authors should ensure, as part of the informed consent procedure, that the participants are made aware what kind of (personal) data will be processed, how it will be used and for what purpose. In case of data acquired via a biobank/biorepository, it is possible they apply a broad consent which allows research participants to consent to a broad range of uses of their data and samples which is regarded by research ethics committees as specific enough to be considered “informed”. However, authors should always check the specific biobank/biorepository policies or any other type of data provider policies (in case of non-bio research) to be sure that this is the case.
Consent to Participate
For all research involving human subjects, freely-given, informed consent to participate in the study must be obtained from participants (or their parent or legal guardian in the case of children under 16) and a statement to this effect should appear in the manuscript. In the case of articles describing human transplantation studies, authors must include a statement declaring that no organs/tissues were obtained from prisoners and must also name the institution(s)/clinic(s)/department(s) via which organs/tissues were obtained. For manuscripts reporting studies involving vulnerable groups where there is the potential for coercion or where consent may not have been fully informed, extra care will be taken by the editor and may be referred to the Springer Nature Research Integrity Group.
Consent to Publish
Individuals may consent to participate in a study, but object to having their data published in a journal article. Authors should make sure to also seek consent from individuals to publish their data prior to submitting their paper to a journal. This is in particular applicable to case studies.
Summary of requirements
The above should be summarized in a statement and placed in a ‘Declarations’ section before the reference list under a heading of ‘Consent to participate’ and/or ‘Consent to publish’. Other declarations include Funding, Competing interests, Ethics approval, Consent, Data and/or Code availability and Authors’ contribution statements.
Please see the various examples of wording below and revise/customize the sample statements according to your own needs.
Sample statements for "Consent to participate":
Informed consent was obtained from all individual participants included in the study.
Informed consent was obtained from legal guardians.
Written informed consent was obtained from the parents.
Verbal informed consent was obtained prior to the interview.
Sample statements for “Consent to publish”:
The authors affirm that human research participants provided informed consent for publication of the images in Figure(s) 1a, 1b and 1c.
The participant has consented to the submission of the case report to the journal.
Patients signed informed consent regarding publishing their data and photographs.
Sample statements if identifying information about participants is available in the article:
Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.
Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Principles. The Editor-in-Chief reserves the right to reject submissions that do not meet the guidelines described in this section.
Images will be removed from publication if authors have not obtained informed consent or the paper may be removed and replaced with a notice explaining the reason for removal.
Research Data Policy and Data Availability Statements
The journal strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files whenever possible.
General repositories - for all types of research data - such as figshare and Dryad may be used where appropriate.
Datasets that are assigned digital object identifiers (DOIs) by a data repository may be cited in the reference list. Data citations should include the minimum information recommended by DataCite: authors, title, publisher (repository name), identifier.
Where a widely established research community expectation for data archiving in public repositories exists, submission to a community-endorsed, public repository is mandatory. Persistent identifiers (such as DOIs and accession numbers) for relevant datasets must be provided in the paper.
If the journal that you’re submitting to uses double-blind peer review and you are providing reviewers with access to your data (for example via a repository link, supplementary information or data on request), it is strongly suggested that the authorship in the data is also blinded. There are data repositories that can assist with this and/or will create a link to mask the authorship of your data.
For the following types of data set, submission to a community-endorsed, public repository is mandatory:
|
Mandatory deposition |
Suitable repositories |
|
Protein sequences |
Uniprot |
|
DNA and RNA sequences |
Genbank DNA DataBank of Japan (DDBJ) EMBL Nucleotide Sequence Database (ENA) |
|
DNA and RNA sequencing data |
NCBI Trace Archive NCBI Sequence Read Archive (SRA) |
|
Genetic polymorphisms |
dbSNP dbVar European Variation Archive (EVA) |
|
Linked genotype and phenotype data |
dbGAP The European Genome-phenome Archive (EGA) |
|
Macromolecular structure |
Worldwide Protein Data Bank (wwPDB) Biological Magnetic Resonance Data Bank (BMRB) Electron Microscopy Data Bank (EMDB) |
|
Microarray data (must be MIAME compliant) |
Gene Expression Omnibus (GEO) ArrayExpress |
|
Crystallographic data for small molecules |
Cambridge Structural Database |
Data availability
The journal encourages authors to provide a statement of Data availability in their article. Data availability statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether data are available on request from the authors and where no data are available, if appropriate.
Data Availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):
More examples of template data availability statements, which include examples of openly available and restricted access datasets, are available:
Authors who need help understanding our data sharing policies, help finding a suitable data repository, or help organising and sharing research data can access.
After Acceptance
Upon acceptance, your article will be exported to Production to undergo typesetting. An e-mail will be received after typesetting for final approval.
Color illustrations
Publication of color illustrations is free of charge.
Proof reading
The purpose of the proof is to check for typesetting or conversion errors and the completeness and accuracy of the text, tables and figures. Substantial changes in content, e.g., new results, corrected values, title and authorship, are not allowed without the approval of the Editor.
After publication, further changes will not be allowed.
The journal is committed to maintaining the highest level of integrity in the content published.
This journal has a competing interest policy in place.
NBEJMS journal require authors to comply with international, national and/or institutional standards of research reporting. This is particularly important for studies involving human and/or animal participants, their data and biological material, and Informed Consent.
The journal is a member of the Committee on Publication Ethics (COPE). It subscribes to COPE's principles for addressing misconduct. This means the journal is committed to investigating any allegations of misconduct, to maintain the integrity of research.
The journal may use plagiarism detection software to screen submissions. If plagiarism is identified, the (COPE) guidelines on plagiarism will be followed.
Content published in this journal is peer reviewed (double-anonymous peer review).
Pre-publication proofs and offprints
Proofs of articles, prior to their publication, are provided to authors. These will be sent electronically (email). The authors may make only the necessary minor corrections at this stage and should answer any queries marked for their attention. The proofs should be returned, after corrections and answering all queries, within 2 days electronically to acad@natboard.edu.in. A delay in returning proofs may lead to a delay in publication..
Rejection
Based on the comments of reviewers and in conformity with the policies of the Journal, manuscripts found unsuitable for publication will be rejected. The corresponding author will be informed of the rejection, and comments of the reviewers, if relevant, will be provided. The manuscript will not be returned.
Appeal process
In case the authors so desire, a rejected manuscript can be resubmitted for fresh consideration. The authors must provide reasons for their disagreement with the reviewers’ comments and justify the need for a reconsideration. The Journal may use its discretion to decide whether or not to submit the manuscript for a fresh review.
Address manuscripts to
National Board of Examinations
Medical Enclave, Ansari Nagar, Mahatma Gandhi Marg, Ring Road, New Delhi,
Delhi 110029
e-mail: acad[at]natboard[dot]edu[dot]in
Authors’ Declaration
We, the authors of the manuscript titled ___________________________________________ , hereby submit it for consideration for publication as a ___________________________________________(category) in National Board of Examinations Journal of Medical Sciences. We agree to the following:
|
Author |
Name |
Signature |
|
First |
_________________________ |
_________________________ |
|
Second |
_________________________ |
_________________________ |
|
Third |
_________________________ |
_________________________ |
|
Fourth |
_________________________ |
_________________________ |
|
Fifth |
_________________________ |
_________________________ |
Publication/Processing Fee
Article Processing Charge
National Board of Examinations Journal of Medical Sciences does not charge the authors or authors’ institutions for the submission, processing and/or publications of manuscripts.
Copyright and Open Access Statement
All of the content published in the National Board of Examination Journal of Medical Sciences is protected under the International copyright law, defined by Creative Commons and International Council of Medical Journal Editors (ICMJE). The journal retains the commercial rights of the published content and publisher executes the commercial rights on behalf of the journal. The journal also grants to all readers and users a free, irrevocable, global, perpetual right of access to, and a license to copy, use, distribute and display the content publicly and to make and distribute derivative works in any digital medium for any reasonable and non-commercial purpose, subject to proper attribution of authorship and ownership of the copyrights under the Creative Commons Attribution-Noncommercial-Share Alike 4.0 International Public License.
Open Access Publication and Creative Commons Licensing
National Board of Examination Journal of Medical Sciences is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Compliance with Funder-Mandated Open Access Policies. An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution-Non-Commercial-Share Alike 4.0 License is able to meet that requirement through the available open-access license for approved funders.
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party. For any Questions or Difficulties please contact us acad[at]natboard[dot]edu[dot]in .